Mitsubishi UFJ Trust & Banking Corp decreased its stake in Teleflex Incorporated (NYSE:TFX) by 61.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,050 shares of the medical technology company’s stock after selling 56,747 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned 0.08% of Teleflex worth $9,326,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. DekaBank Deutsche Girozentrale boosted its holdings in Teleflex by 7.0% in the third quarter. DekaBank Deutsche Girozentrale now owns 3,235 shares of the medical technology company’s stock worth $856,000 after acquiring an additional 213 shares in the last quarter. FMR LLC boosted its holdings in Teleflex by 632.5% in the third quarter. FMR LLC now owns 1,343,305 shares of the medical technology company’s stock worth $357,440,000 after acquiring an additional 1,159,914 shares in the last quarter. Fairview Capital Investment Management LLC boosted its holdings in Teleflex by 0.6% in the third quarter. Fairview Capital Investment Management LLC now owns 187,924 shares of the medical technology company’s stock worth $50,005,000 after acquiring an additional 1,111 shares in the last quarter. Rafferty Asset Management LLC bought a new position in Teleflex in the third quarter worth approximately $868,000. Finally, American International Group Inc. boosted its holdings in Teleflex by 1.6% in the third quarter. American International Group Inc. now owns 93,143 shares of the medical technology company’s stock worth $24,784,000 after acquiring an additional 1,430 shares in the last quarter. 92.42% of the stock is owned by institutional investors.

In other Teleflex news, insider Thomas E. Powell sold 5,200 shares of the firm’s stock in a transaction on Friday, November 23rd. The stock was sold at an average price of $254.10, for a total value of $1,321,320.00. Following the completion of the sale, the insider now directly owns 15,351 shares of the company’s stock, valued at $3,900,689.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Benson Smith sold 9,331 shares of the firm’s stock in a transaction on Monday, September 17th. The stock was sold at an average price of $266.73, for a total value of $2,488,857.63. Following the completion of the sale, the director now directly owns 77,887 shares of the company’s stock, valued at $20,774,799.51. The disclosure for this sale can be found here. Insiders have sold 82,329 shares of company stock valued at $21,275,053 over the last ninety days. 2.56% of the stock is currently owned by company insiders.

Shares of TFX opened at $268.05 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.26 and a quick ratio of 1.51. The company has a market cap of $12.24 billion, a P/E ratio of 31.91, a price-to-earnings-growth ratio of 2.15 and a beta of 1.14. Teleflex Incorporated has a 12 month low of $227.52 and a 12 month high of $288.78.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, November 1st. The medical technology company reported $2.52 EPS for the quarter, beating the Zacks’ consensus estimate of $2.41 by $0.11. The company had revenue of $609.70 million during the quarter, compared to the consensus estimate of $609.05 million. Teleflex had a return on equity of 18.04% and a net margin of 2.81%. Teleflex’s revenue was up 14.0% on a year-over-year basis. During the same period last year, the business posted $2.12 earnings per share. On average, equities research analysts predict that Teleflex Incorporated will post 9.91 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 14th. Investors of record on Thursday, November 15th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date of this dividend is Wednesday, November 14th. Teleflex’s payout ratio is 16.19%.

TFX has been the topic of several recent research reports. TheStreet upgraded Teleflex from a “c+” rating to a “b-” rating in a report on Wednesday, November 28th. UBS Group started coverage on Teleflex in a report on Tuesday, November 27th. They issued a “buy” rating and a $310.00 price target on the stock. ValuEngine upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, September 13th. Needham & Company LLC restated a “buy” rating and issued a $315.00 target price on shares of Teleflex in a report on Friday, November 2nd. Finally, Barclays started coverage on Teleflex in a report on Monday, October 15th. They issued an “equal weight” rating and a $266.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $291.67.

ILLEGAL ACTIVITY WARNING: “Mitsubishi UFJ Trust & Banking Corp Sells 56,747 Shares of Teleflex Incorporated (TFX)” was originally published by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.dailypolitical.com/2018/12/07/mitsubishi-ufj-trust-banking-corp-sells-56747-shares-of-teleflex-incorporated-tfx.html.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Featured Article: How to calculate the annual rate of depreciation

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.